{"id":7104,"date":"2015-08-19T22:59:55","date_gmt":"2015-08-19T21:59:55","guid":{"rendered":"http:\/\/k2info.w.uib.no\/?p=7104"},"modified":"2015-08-21T09:00:42","modified_gmt":"2015-08-21T08:00:42","slug":"3rd-annual-congress-european-society-for-translational-medicine","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/nb_no\/2015\/08\/19\/3rd-annual-congress-european-society-for-translational-medicine\/","title":{"rendered":"3rd Annual Congress European Society for Translational Medicine"},"content":{"rendered":"

[:no]1-4 September, Vienna, AustriaUnderstand Benchside – Bedside – Benchside Pathways.
\nHow to Accelerate Research & Development and Reduce Associated Heavy Cost?
\nREGISTER at: http:\/\/eutranslationalmedicine.org\/registration\/
\n<\/a>Preliminary program:\u00a0http:\/\/eutranslationalmedicine.org\/preliminary-agenda<\/a><\/p>\n

Programme Overview:<\/p>\n

Pre Conference Workshop: Systems modeling of disease mechanism for target\/biomarker identification.
\n<\/strong>Instructor: Dr. Erfan Younesi, PhD\u00a0Fraunhofer Institute, Germany.
\nFor more information:\u00a0http:\/\/eutranslationalmedicine.org\/workshops-2\/<\/a><\/p>\n

Panel Discussion: New Horizons in Personalized Medicine<\/strong>
\nChair :Aamir Shahzad, President, European Society for Translational Medicine (EUSTM)
\nUlrich Pfeffer, Head, Functional Genomics lab, National Institute for Cancer Research, IST, Genova, Italy
\nErfan Younesi, Fraunhofer Institute for Algorithms & Scientific Computing SCAI, Sankt Augustin, Germany
\nAlexandre Passioukov,Vice President, Translational Medicine, Pierre Fabre, Toulouse, France<\/p>\n

Panel Discussion: New Horizons in drug discovery & development
\n<\/strong>Chair: Laurent AUDOLY, Senior Vice President R&D, Global Head of Drug Development and Translational Medicine, France.
\nAraz Raoof, Vice President, Global Functional Head C.R.E.A.Te Johnson & Johnson, Antwerp, Belgium
\nDaniel Strasser, Senior Lab Head, Translational Science Drug Discovery Biology, Actelion Pharmaceuticals Ltd, Switzerland
\nAndr\u00e9 Nogueira da Costa, Department of Non-Clinical Development, UCB BioPharma SPRL, Belgium.<\/p>\n

Satellite Symposium: New Horizons in Data Mining & Management
\n<\/strong>Talks:
\nBridging the Gap between Translational Research and Precision Medicine Clinical Workflow<\/em>
\nWanmei ou,\u00a0<\/strong>Oracle Health Sciences, Burlington, MA, USA.
\nExperiences and challenges in running a Bioinformatics Core facility
\n<\/strong><\/em>Puthen Veettil Jithesh, Sidra Medical and Research Center, Doha, Qatar<\/p>\n

Discussion Panel:
\nAntonio Facchiano,\u00a0Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, Rome, Italy.
\nWanmei ou,\u00a0Oracle Health Sciences, Burlington, MA, USA.
\nPuthen Veettil Jithesh,\u00a0Sidra Medical and Research Center, Doha, Qatar<\/p>\n


\nKey Opinion Leaders (KOLs) from including Academia, Industry & NASA (30 countries)<\/strong><\/p>\n

* Marianna Bei, Harvard Medical School & Massachusetts General Hospital,Boston, USA
\n* Adriana Albini, Scientific Director Fondazione Multimedica ONLUS, Milan, Italy
\n* Sinisa Dovat, Director, Translational Research, Pennsylvania State University, College of Medicine, Pennsylvania, USA
\n* Beatrice Bachmeier, Inst. of Laboratory Medicine, Ludwig-Maximilians-University, Munich, Germany
\n* Roy Goodacre, School of Chemistry, The University of Manchester, Manchester, UK
\n* Zhaohua Zhong, Deputy Dean, Department of Microbiology, Harbin Medical University, Harbin, China
\n* Thomas J. Goodwin, Houston, USA
\n* Ulrich Pfeffer, Head, Functional Genomics lab, National Institute for Cancer Research, IST, Genova, Italy
\n* Carlos Martinez Salgado, Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n, Spain
\n* Fr\u00e9d\u00e9ric Chibon, INSERM U916 \u2013 Institut Bergoni\u00e9, Bordeaux, France
\n* Martine J. Jager, Head, Laboratory of Ophthalmology, Leiden University, The Netherlands
\n* Edwin Bremer, University of Groningen, University Medical Center Groningen (UMCG), The Netherlands
\n* Francisco J. Lopez-Hernandez, University Hospital of Salamanca, IBSAL, Salamanca, Spain
\n* Antonio Facchiano, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, Rome, Italy
\n* Kunlun He, Department of Translational Medicine, Chinese PLA General Hospital, Beijing, China
\n* Vasso Terzidou, ObsEva SA, Geneva, Switzerland
\n* Chiara Castellani, Dept. of Cardiac, Thoracic and Vascular Sciences, University of Padua, Italy
\n* Mauro Cataldi, Department of Neuroscience, Federico II University of Naples, Napoli, Italy
\n* Wanmei ou, Oracle Health Sciences, Burlington, MA, USA
\n* Puthen Veettil Jithesh, Sidra Medical and Research Center, Doha, Qatar
\n* Randal J Cohrs, Vice President, European Society for Translational Medicine
\n* Matthias Nees, Turku Centre for Biotechnology, Turku, Finland
\n* Elizabeth K. Leffel, Leffel Consulting Group, LLC, Terapio, Austin, Texas, USA
\n* Gottfried K\u00f6hler, CEO, OnkoTec, Austria
\n* Tomasz Schneider, Durham University School of Medicine, Pharmacy & Health, Stockton-on-Tees, UK
\n* John P. Hays, Erasmus University Medical Centre, Rotterdam, The Netherlands
\n* Wanmei ou, Oracle Health Sciences, Burlington, MA, USA
\n* Kristina Djinovic-Carugo, Max F. Perutz Laboratories, University of Vienna, Austria
\n* J Sivaraman, Department of Biological Sciences, National University of Singapore, Singapore
\n* Roberta Tasso, Laboratory of Regenerative Medicine DIMES, University of Genova & A.O.U. San Martino-IST, Genova, Italy
\n* Frank Staubli, Nebion AG, Zurich, Switzerland
\n* Daniel Strasser, Actelion Pharmaceuticals Ltd, Switzerland
\n* Aamir Shahzad, President, European Society for Translational Medicine
\n* Andr\u00e9 Nogueira da Costa, Department of Non-Clinical Development, UCB BioPharma SPRL, Belgium
\n* Araz A. Raoof, Vice President, Global Functional Head C.R.E.A.Te, Janssen Pharamecutica, Belgium
\n* Michael A. Schmidt, Colorado State University, Colorado, USA
\n* Rebecca Morris, University of Manchester, Manchester, UK
\n* Laurent AUDOLY, Sr. VP R&D, Global Head, Drug Development & Translational Medicine, France
\n* Alessandro Weisz, Lab. Mol. Medicine and Genomics, University of Salerno, Salerno, Italy
\n* Alexandre Passioukov, Vice President, Translational Medicine, Pierre Fabre, Toulouse, France[:en]1-4 September, Vienna, AustriaUnderstand Benchside – Bedside – Benchside Pathways.
\nHow to Accelerate Research & Development and Reduce Associated Heavy Cost?
\nREGISTER at: http:\/\/eutranslationalmedicine.org\/registration\/
\n<\/a>Preliminary program:\u00a0http:\/\/eutranslationalmedicine.org\/preliminary-agenda<\/a><\/p>\n

Programme Overview:<\/p>\n

Pre Conference Workshop: Systems modeling of disease mechanism for target\/biomarker identification.
\n<\/strong>Instructor: Dr. Erfan Younesi, PhD\u00a0Fraunhofer Institute, Germany.
\nFor more information:\u00a0http:\/\/eutranslationalmedicine.org\/workshops-2\/<\/a><\/p>\n

Panel Discussion: New Horizons in Personalized Medicine<\/strong>
\nChair :Aamir Shahzad, President, European Society for Translational Medicine (EUSTM)
\nUlrich Pfeffer, Head, Functional Genomics lab, National Institute for Cancer Research, IST, Genova, Italy
\nErfan Younesi, Fraunhofer Institute for Algorithms & Scientific Computing SCAI, Sankt Augustin, Germany
\nAlexandre Passioukov,Vice President, Translational Medicine, Pierre Fabre, Toulouse, France<\/p>\n

Panel Discussion: New Horizons in drug discovery & development
\n<\/strong>Chair: Laurent AUDOLY, Senior Vice President R&D, Global Head of Drug Development and Translational Medicine, France.
\nAraz Raoof, Vice President, Global Functional Head C.R.E.A.Te Johnson & Johnson, Antwerp, Belgium
\nDaniel Strasser, Senior Lab Head, Translational Science Drug Discovery Biology, Actelion Pharmaceuticals Ltd, Switzerland
\nAndr\u00e9 Nogueira da Costa, Department of Non-Clinical Development, UCB BioPharma SPRL, Belgium.<\/p>\n

Satellite Symposium: New Horizons in Data Mining & Management
\n<\/strong>Talks:
\nBridging the Gap between Translational Research and Precision Medicine Clinical Workflow<\/em>
\nWanmei ou,\u00a0<\/strong>Oracle Health Sciences, Burlington, MA, USA.
\nExperiences and challenges in running a Bioinformatics Core facility
\n<\/strong><\/em>Puthen Veettil Jithesh, Sidra Medical and Research Center, Doha, Qatar<\/p>\n

Discussion Panel:
\nAntonio Facchiano,\u00a0Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, Rome, Italy.
\nWanmei ou,\u00a0Oracle Health Sciences, Burlington, MA, USA.
\nPuthen Veettil Jithesh,\u00a0Sidra Medical and Research Center, Doha, Qatar<\/p>\n


\nKey Opinion Leaders (KOLs) from including Academia, Industry & NASA (30 countries)<\/strong><\/p>\n

* Marianna Bei, Harvard Medical School & Massachusetts General Hospital,Boston, USA
\n* Adriana Albini, Scientific Director Fondazione Multimedica ONLUS, Milan, Italy
\n* Sinisa Dovat, Director, Translational Research, Pennsylvania State University, College of Medicine, Pennsylvania, USA
\n* Beatrice Bachmeier, Inst. of Laboratory Medicine, Ludwig-Maximilians-University, Munich, Germany
\n* Roy Goodacre, School of Chemistry, The University of Manchester, Manchester, UK
\n* Zhaohua Zhong, Deputy Dean, Department of Microbiology, Harbin Medical University, Harbin, China
\n* Thomas J. Goodwin, Houston, USA
\n* Ulrich Pfeffer, Head, Functional Genomics lab, National Institute for Cancer Research, IST, Genova, Italy
\n* Carlos Martinez Salgado, Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n, Spain
\n* Fr\u00e9d\u00e9ric Chibon, INSERM U916 \u2013 Institut Bergoni\u00e9, Bordeaux, France
\n* Martine J. Jager, Head, Laboratory of Ophthalmology, Leiden University, The Netherlands
\n* Edwin Bremer, University of Groningen, University Medical Center Groningen (UMCG), The Netherlands
\n* Francisco J. Lopez-Hernandez, University Hospital of Salamanca, IBSAL, Salamanca, Spain
\n* Antonio Facchiano, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, Rome, Italy
\n* Kunlun He, Department of Translational Medicine, Chinese PLA General Hospital, Beijing, China
\n* Vasso Terzidou, ObsEva SA, Geneva, Switzerland
\n* Chiara Castellani, Dept. of Cardiac, Thoracic and Vascular Sciences, University of Padua, Italy
\n* Mauro Cataldi, Department of Neuroscience, Federico II University of Naples, Napoli, Italy
\n* Wanmei ou, Oracle Health Sciences, Burlington, MA, USA
\n* Puthen Veettil Jithesh, Sidra Medical and Research Center, Doha, Qatar
\n* Randal J Cohrs, Vice President, European Society for Translational Medicine
\n* Matthias Nees, Turku Centre for Biotechnology, Turku, Finland
\n* Elizabeth K. Leffel, Leffel Consulting Group, LLC, Terapio, Austin, Texas, USA
\n* Gottfried K\u00f6hler, CEO, OnkoTec, Austria
\n* Tomasz Schneider, Durham University School of Medicine, Pharmacy & Health, Stockton-on-Tees, UK
\n* John P. Hays, Erasmus University Medical Centre, Rotterdam, The Netherlands
\n* Wanmei ou, Oracle Health Sciences, Burlington, MA, USA
\n* Kristina Djinovic-Carugo, Max F. Perutz Laboratories, University of Vienna, Austria
\n* J Sivaraman, Department of Biological Sciences, National University of Singapore, Singapore
\n* Roberta Tasso, Laboratory of Regenerative Medicine DIMES, University of Genova & A.O.U. San Martino-IST, Genova, Italy
\n* Frank Staubli, Nebion AG, Zurich, Switzerland
\n* Daniel Strasser, Actelion Pharmaceuticals Ltd, Switzerland
\n* Aamir Shahzad, President, European Society for Translational Medicine
\n* Andr\u00e9 Nogueira da Costa, Department of Non-Clinical Development, UCB BioPharma SPRL, Belgium
\n* Araz A. Raoof, Vice President, Global Functional Head C.R.E.A.Te, Janssen Pharamecutica, Belgium
\n* Michael A. Schmidt, Colorado State University, Colorado, USA
\n* Rebecca Morris, University of Manchester, Manchester, UK
\n* Laurent AUDOLY, Sr. VP R&D, Global Head, Drug Development & Translational Medicine, France
\n* Alessandro Weisz, Lab. Mol. Medicine and Genomics, University of Salerno, Salerno, Italy
\n* Alexandre Passioukov, Vice President, Translational Medicine, Pierre Fabre, Toulouse, France[:]<\/p>\n","protected":false},"excerpt":{"rendered":"

[:no]1-4 September, Vienna, Austria<\/p>\n

Read more →<\/a><\/p>\n","protected":false},"author":3238,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44,45498],"tags":[64947],"class_list":["post-7104","post","type-post","status-publish","format-standard","hentry","category-nyheter","category-seminar-kurs-og-konferanser","tag-64947"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/7104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/users\/3238"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/comments?post=7104"}],"version-history":[{"count":9,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/7104\/revisions"}],"predecessor-version":[{"id":7113,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/7104\/revisions\/7113"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/media?parent=7104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/categories?post=7104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/tags?post=7104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}